SecBot SecBot
SC 13G/A ·Filed Oct 30, 2026

ELDN

Eledon Pharmaceuticals, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed2d 9h ago SEC0002100119-26-001561
Passive stake amendment
Actionable Insight • Neutral

Vanguard's reduction below 5% removes a passive overhang but signals no active conviction. Monitor for further selling or a full exit in the next 13G filing.

DirectionNeutral
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

Executive Summary

Vanguard Capital Management LLC filed an amended Schedule 13G disclosing a 4.87% passive stake in Eledon Pharmaceuticals as of September 30, 2026, down from its prior 5%+ position. The filing confirms the fund remains a passive investor and has reduced its holdings below the 5% threshold.

Key Financial Metrics

Stake
4.87%
Investor
Vanguard Capital Management LLC
Investor Type
mutual fund

Key Facts

  • Vanguard Capital Management LLC reported beneficial ownership of 3,957,862 shares of Eledon Pharmaceuticals common stock as of September 30, 2026.
  • The stake represents 4.87% of shares outstanding, down from the previously reported 5%+ level.
  • The filing is an amendment to Schedule 13G under Rule 13d-1(b), confirming passive investment intent.
  • Vanguard Capital Management LLC exercises sole dispositive power over all 3,957,862 shares and sole voting power over 540,639 shares.

Financial Impact

Stake reduction from above 5% to 4.87%; no dollar value stated in filing.

ownership_percentage

Risk Factors

  • Continued passive selling by Vanguard could pressure the stock.
  • No activist intent indicated; filing is routine for a passive index/asset manager.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0002100119-26-001561
Document: 0002100119-26-001561-index.html0002100119-26-001561
Document: 0002100119-26-001561.txt0002100119-26-001561
6 reports for ELDN
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ELDN, sortable and filterable
TypeNow
Oct 30, 2026
2d ago
SC 13G/A
NEUTRAL ★ 3/10
$2.91awaiting T+20awaiting T+20$2.77 (−4.81%)
Sep 22, 2026
5w ago
Institutional Cluster
BULLISH ★ 4/10
$2.89 $2.26▼ −21.97%▼ −21.41%$2.77 (−4.15%)
Sep 22, 2026
5w ago
Press Release
BULLISH ★ 7/10
$2.89 $2.26▼ −21.97%▼ −21.41%$2.77 (−4.15%)
May 20, 2026
23w ago
Press Release
NEUTRAL ★ 3/10
$3.89 $3.82▼ −1.93%▼ −2.26%$2.77 (−28.79%)
Mar 10, 2026
33w ago
Press Release
MIXED ★ 6/10
$2.90 $3.13▲ +7.93%▲ +8.09%$2.77 (−4.48%)
Feb 28, 2026
35w ago
Institutional Cluster
NEUTRAL ★ 4/10
$2.66 $2.71▲ +1.88%▲ +9.82%$2.77 (+4.14%)
Showing 6 of 6

US Market Status

Market Closed · Opens Tue (13h 7m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 30, 2026